SCN5A and cardiac arrhythmia: Furthermore, other studies have reported pathogenic mutations in BRCA1 in women without a family history of breast cancer and pathogenic mutations in SCN5A or KCNH2 in patients without phenotypic and electrophysiological evidence of cardiac arrhythmias [36, 37].